5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

October 24, 2025 to October 25, 2025

Overview

The 5th Binaytara Precision Oncology Summit is a two-day, CME-accredited national conference bringing together leading experts and oncology professionals to explore cutting-edge developments in precision oncology. With the theme "Redefining Cancer Treatment with Molecular Targeted Strategies," this summit emphasizes the integration of genomics, novel therapies, and emerging technologies into routine cancer care.

The program features a robust mix of didactic lectures, case-based discussions, panel sessions, molecular tumor boards, abstract presentations, and roundtables, all designed to foster clinical insights and multidisciplinary collaboration. An audience response system will be used throughout the event to engage participants in real-time learning and decision-making.

Key topics include:

  • Advances in genomic medicine and biomarker discovery
  • Germline and somatic profiling in treatment planning
  • Pathway-based therapies, liquid biopsy, and non-invasive diagnostics
  • Artificial intelligence in oncology
  • Ethical issues and barriers to adoption of precision strategies
  • Personalized cancer vaccines and immunotherapy

This summit equips participants with the latest scientific knowledge and practical tools to deliver personalized, evidence-based cancer care. Designed for oncologists, hematologists, pathologists, pharmacists, nurse practitioners, and other healthcare professionals, the event provides a unique opportunity to deepen understanding and improve patient outcomes through precision oncology.

Target Audience

  • Hematologists/Oncologists
  • Oncology Nurse Practitioners
  • Oncology Pharmacists
  • Oncology Physician Assistants
  • Oncology Fellows/Residents
  • Oncology Nurses
  • Researchers and others involved in the care of cancer patients

Organizing Committee 

Program Director:

  • Binay Shah, MD, MHA - Binaytara

Conference Chair:

  • Mark Pegram, MD - Stanford University 

Learning Objectives

At the conclusion of this activity, participants will be able to:

  1. Apply current advances in genomic profiling, including germline and somatic testing, to guide individualized cancer treatment strategies.
  2. Evaluate and select appropriate molecular-targeted therapies, including pathway-based agents, immunotherapies, and personalized cancer vaccines.
  3. Interpret results from liquid biopsy, next-generation sequencing, and other molecular diagnostics to inform clinical decision-making.
  4. Analyze complex real-world cases presented in molecular tumor boards and implement evidence-based, patient-centered precision oncology approaches.
  5. Identify ethical, technological, and systemic challenges—including the role of AI and healthcare disparities—in the clinical adoption of precision oncology, and propose strategies to overcome them.
Course summary
Course opens: 
04/01/2025
Course expires: 
01/18/2026
Event starts: 
10/24/2025 - 8:00am PDT
Event ends: 
10/25/2025 - 5:00pm PDT
Cost:
$350.00

Program

DAY 1 - OCTOBER 24th, 2025

All times listed in Pacific Daylight Time (PDT).

09:00 AM – 10:00 AM  Registration, Breakfast, and Exhibits


10:00 AM – 10:15 AM  Welcome


10:15 AM – 11:00 AM  Plenary Speech - Advances in Genomic Medicine


11:00 AM – 12:00 PM  Session 1: Genomic Profiling in Cancer

Session Chair: 

11:00 AM – 11:20 AM  Keynote Speech: Germ Line Testing in Cancer Treatment: From Sequencing to Clinical Application -

11:20 AM – 12:00 PM  Panel Discussion


12:00 PM – 01:00 PM  Lunch & Exhibits


01:00 PM – 02:00 PM  Session 2: Pathway-Based Targeted Therapies in Oncology

Session Chair: 

01:00 PM – 01:20 PM  Keynote Speech

01:20 PM – 02:00 PM  Case-Based Discussion


02:00 PM – 03:00 PM  Session 3: Molecular Tumor Board 1: Interesting and Challenging Cases in Precision Oncology

Session Chair: 

Case Presenters:


03:00 PM – 03:30 PM  Break & Exhibits


03:30 PM – 04:00 PM  Session 4: Liquid Biopsy and Non-Invasive Testing

Session Chair:


04:00 PM – 04:30 PM  Session 5: Roundtable Discussion: Ethical Challenges in Precision Oncology

Session Chair:

Panelists:


04:30 PM – 05:15 PM  Session 6: Personalized Cancer Vaccines in Immuno-oncology

Session Chair: 

04:30 PM – 04:45 PM  Development of Personalized Cancer Vaccines and Immunotherapy - 

04:45 PM – 05:15 PM  Panel Discussion


05:15 PM  Adjourn


05:15 PM – 06:15 PM  Networking Reception
 

DAY 2 - OCTOBER 25th, 2025

07:00 AM – 08:00 AM  Registration, Breakfast, and Exhibits 


08:00 AM – 09:15 AM  Session 6: Artificial Intelligence in Precision Oncology

Session Chair: 


09:15 AM – 10:15 AM  Session 7: Oral Abstract Presentations

Session Chair: 


10:15 AM – 10:45 AM  Break & Exhibits


10:45 AM – 11:15 AM  Binaytara’s Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA


11:15 AM – 12:15 PM  Session 8: Panel Discussion: Practical Challenges and Barriers in Clinical Adoption of Precision Oncology

Session Chair:

Panelists:


12:15 PM – 01:15 PM  Lunch & Exhibits


01:15 PM – 02:45 PM  Session 9: Molecular Tumor Board 2: Interesting and Challenging Cases in Precision Oncology

Session Chair:

Case Presenters:


02:45 PM – 03:00 PM  Break & Exhibits


03:00 PM – 04:00 PM  Session 10: The Future of Precision Oncology: Biomarker Discovery and Validation

Session Chair:

03:00 PM – 03:20 PM  Keynote Speech

03:20 PM – 04:00 PM  Panel Discussion 


04:00 PM – 04:45 PM  Session 11: Roundtable Discussion: The Future of Precision Oncology

Session Chair:

Panelists:


04:45 PM – 05:00 PM  Closing Remarks and Thank You


05:00 PM  Adjourn

Faculty

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

 

Exhibitors

If you are interested in exhibiting at this meeting or purchasing a badge with your company at our discounted rate for exhibitors, please visit our exhibit page here - https://www.sponsorships.binayfoundation.org/Exhibit

 

Register/Take course

Price

Cost:
$350.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.